Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

889 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Pediatric intracranial ependymoma: correlating signs and symptoms at recurrence with outcome in the second prospective AIEOP protocol follow-up.
Massimino M, Barretta F, Modena P, Giangaspero F, Chiapparini L, Erbetta A, Boschetti L, Antonelli M, Ferroli P, Bertin D, Pecori E, Biassoni V, Garrè ML, Schiavello E, Sardi I, Viscardi E, Scarzello G, Mascarin M, Quaglietta L, Cinalli G, Genitori L, Peretta P, Mussano A, Barra S, Mastronuzzi A, Giussani C, Marras CE, Balter R, Bertolini P, Tornesello A, La Spina M, Buttarelli FR, Ruggiero A, Caldarelli M, Poggi G, Gandola L. Massimino M, et al. Among authors: ruggiero a. J Neurooncol. 2018 Nov;140(2):457-465. doi: 10.1007/s11060-018-2974-6. Epub 2018 Aug 14. J Neurooncol. 2018. PMID: 30109673
Hypersensitivity reactions to carboplatin in children.
Lazzareschi I, Ruggiero A, Riccardi R, Attinà G, Colosimo C, Lasorella A. Lazzareschi I, et al. Among authors: ruggiero a. J Neurooncol. 2002 May;58(1):33-7. doi: 10.1023/a:1015853200090. J Neurooncol. 2002. PMID: 12160138
High response rate to cisplatin/etoposide regimen in childhood low-grade glioma.
Massimino M, Spreafico F, Cefalo G, Riccardi R, Tesoro-Tess JD, Gandola L, Riva D, Ruggiero A, Valentini L, Mazza E, Genitori L, Di Rocco C, Navarria P, Casanova M, Ferrari A, Luksch R, Terenziani M, Balestrini MR, Colosimo C, Fossati-Bellani F. Massimino M, et al. Among authors: ruggiero a. J Clin Oncol. 2002 Oct 15;20(20):4209-16. doi: 10.1200/JCO.2002.08.087. J Clin Oncol. 2002. PMID: 12377964 Clinical Trial.
Pharmacokinetics of temozolomide given three times a day in pediatric and adult patients.
Riccardi A, Mazzarella G, Cefalo G, Garrè ML, Massimino M, Barone C, Sandri A, Ridola V, Ruggiero A, Mastrangelo S, Lazzareschi I, Caldarelli M, Maira G, Madon E, Riccardi R. Riccardi A, et al. Among authors: ruggiero a. Cancer Chemother Pharmacol. 2003 Dec;52(6):459-64. doi: 10.1007/s00280-003-0677-x. Epub 2003 Sep 16. Cancer Chemother Pharmacol. 2003. PMID: 13680160 Clinical Trial.
Massive congenital intracranial teratoma: perioperative coagulation impairment.
Piastra M, Decarolis MP, Tempera A, Caresta E, Polidori G, Chiaretti A, Pietrini D, Ruggiero A, Caldarelli M, Di Rocco C. Piastra M, et al. Among authors: ruggiero a. J Pediatr Hematol Oncol. 2004 Nov;26(11):712-7. doi: 10.1097/00043426-200411000-00005. J Pediatr Hematol Oncol. 2004. PMID: 15543004
Phase II trial of temozolomide in children with recurrent high-grade glioma.
Ruggiero A, Cefalo G, Garré ML, Massimino M, Colosimo C, Attinà G, Lazzareschi I, Maurizi P, Ridola V, Mazzarella G, Caldarelli M, Di Rocco C, Madon E, Abate ME, Clerico A, Sandri A, Riccardi R. Ruggiero A, et al. J Neurooncol. 2006 Mar;77(1):89-94. doi: 10.1007/s11060-005-9011-2. J Neurooncol. 2006. PMID: 16292488 Clinical Trial.
Longitudinal assessment of childhood optic gliomas: relationship between flicker visual evoked potentials and magnetic resonance imaging findings.
Falsini B, Ziccardi L, Lazzareschi I, Ruggiero A, Placentino L, Dickmann A, Liotti L, Piccardi M, Balestrazzi E, Colosimo C, Di Rocco C, Riccardi R. Falsini B, et al. Among authors: ruggiero a. J Neurooncol. 2008 May;88(1):87-96. doi: 10.1007/s11060-008-9537-1. Epub 2008 Feb 2. J Neurooncol. 2008. PMID: 18246407
889 results